🔗 Share this article

Chancellor Reeves has stated she is planning "specific action to address cost of living challenges" in next month's financial statement.

In comments to media outlets, she noted that curbing inflation is a collective task of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven advanced economies this year and next.

Possible Utility Cost Interventions

Sources suggest the government could intervene to reduce utility costs, for instance by cutting the current 5% level of value-added tax applied on energy supplies.

Another option is to lower some of the government charges presently included in bills.

Budgetary Limitations and Expert Predictions

The administration will receive the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The view from the majority of experts is that the Chancellor will have to announce higher taxes or expenditure reductions in order to fulfill her self-imposed debt limits.

Earlier on the same day, analysis suggested there was a £22 billion deficit for the Treasury chief to address, which is at the more modest range of expectations.

"It is a collective job between the Bank of England and the administration to further reduce some of the causes of price increases," the Chancellor told the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and International Concerns

While a great deal of the attention has been on likely tax increases, the Treasury chief said the latest data from the OBR had not altered her commitment to manifesto promises not to increase rates on earnings tax, VAT or National Insurance.

She attributed an "uncertain global environment" with rising geopolitical and commercial issues for the fiscal tax moves, likely to be targeted on those "most able to pay."

International Economic Tensions

Referring to concerns about the United Kingdom's trade ties with the Asian nation she said: "Our national security invariably take priority."

Last week's declaration by China to increase export controls on rare earths and other resources that are essential for high-technology production led American leader Donald Trump to propose an further 100% import tax on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two economic giants.

The US Treasury Secretary described China's move "commercial pressure" and "a international production control attempt."

Asked about accepting the American proposal to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by Chinese measures and encouraged the Chinese government "to avoid restrictions and restrict access."

She said the action was "harmful for the world economy and generates additional obstacles."

"In my view there are sectors where we need to challenge China, but there are also important prospects to trade with Chinese markets, including financial services and other sectors of the economic system. We've got to maintain that equilibrium appropriate."

The chancellor also affirmed she was collaborating with other major economies "on our own essential resources approach, so that we are less reliant."

Health Service Drug Pricing and Investment

The Chancellor also acknowledged that the cost the NHS pays for drugs could increase as a result of current talks with the US government and its pharmaceutical firms, in exchange for reduced taxes and capital.

Some of the world's largest drug companies have said in recent statements that they are either delaying or canceling operations in the UK, with several blaming the insufficient payments they are getting.

Recently, the Science Minister said the cost the NHS pays for medicines would need to rise to prevent businesses and pharmaceutical investment departing from the UK.

Reeves informed media: "We have seen due to the cost structure, that clinical trials, innovative medicines have not been available in the United Kingdom in the way that they are in other EU nations."

"We want to make sure that patients getting treatment from the NHS are can receive the finest essential medicines in the globe. And so we are reviewing this situation, and... aiming to secure more capital into the UK."